Mohit Bansal
Stock Analyst at Wells Fargo
(4.77)
# 573
Out of 4,835 analysts
802
Total ratings
62.3%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Mohit Bansal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $80 | $65.68 | +21.80% | 28 | Sep 11, 2026 | |
| AMGN Amgen | Rated: Hold | $400 → $435 | $377.35 | +15.28% | 50 | Sep 4, 2026 | |
| MRK Merck & Co. | Rated: Buy | $150 → $170 | $143.93 | +18.11% | 56 | Sep 4, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Buy | $30 | $17.55 | +70.94% | 13 | Aug 26, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $140 | $96.73 | +44.73% | 13 | Aug 19, 2026 | |
| ABBV AbbVie | Rated: Buy | $295 → $300 | $257.12 | +16.68% | 43 | Aug 17, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $7 | $0.9801 | +614.21% | 5 | Aug 13, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | $55 | $29.34 | +87.46% | 16 | Aug 12, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $750 | $781.49 | -4.03% | 68 | Aug 12, 2026 | |
| VERA Vera Therapeutics | Rated: Buy | $70 | $35.05 | +99.71% | 11 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $245.80 | +22.05% | 20 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 → $95 | $107.20 | -11.38% | 27 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $80 | $66.17 | +20.90% | 23 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 | $143.72 | +14.81% | 64 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,280 → $1,330 | $1,115.70 | +19.21% | 68 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 | $27.72 | +1.01% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $550 | $515.44 | +6.70% | 52 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $60 → $65 | $63.64 | +2.14% | 44 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $156.22 | +28.02% | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $217.15 | +15.13% | 54 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $4.08 | +22.55% | 16 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.59 | +183.22% | 1 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $58.65 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $82.85 | n/a | 1 | Jul 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $14 | $37.44 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.0001 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $1.17 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $33 | $37.59 | n/a | 2 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $1.33 | n/a | 6 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 → $75 | $6.20 | n/a | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $5 | $0.0001 | n/a | 5 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $65 | $33.60 | n/a | 5 | Dec 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $8.5 | $3.29 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.02265 | n/a | 2 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $14.81 | n/a | 1 | Jun 11, 2019 |
BioMarin Pharmaceutical
Sep 11, 2026
Reiterated: Buy
Price Target: $80
Current: $65.68
Upside: +21.80%
Amgen
Sep 4, 2026
Rated: Hold
Price Target: $400 → $435
Current: $377.35
Upside: +15.28%
Merck & Co.
Sep 4, 2026
Rated: Buy
Price Target: $150 → $170
Current: $143.93
Upside: +18.11%
Summit Therapeutics
Aug 26, 2026
Reiterated: Buy
Price Target: $30
Current: $17.55
Upside: +70.94%
BioNTech SE
Aug 19, 2026
Reiterated: Buy
Price Target: $140
Current: $96.73
Upside: +44.73%
AbbVie
Aug 17, 2026
Rated: Buy
Price Target: $295 → $300
Current: $257.12
Upside: +16.68%
Milestone Pharmaceuticals
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $0.9801
Upside: +614.21%
Mineralys Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $55
Current: $29.34
Upside: +87.46%
Regeneron Pharmaceuticals
Aug 12, 2026
Reiterated: Hold
Price Target: $750
Current: $781.49
Upside: -4.03%
Vera Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $70
Current: $35.05
Upside: +99.71%
Aug 10, 2026
Reiterated: Buy
Price Target: $300
Current: $245.80
Upside: +22.05%
Aug 7, 2026
Rated: Hold
Price Target: $75 → $95
Current: $107.20
Upside: -11.38%
Aug 6, 2026
Reiterated: Buy
Price Target: $65 → $80
Current: $66.17
Upside: +20.90%
Aug 5, 2026
Rated: Buy
Price Target: $165
Current: $143.72
Upside: +14.81%
Aug 5, 2026
Rated: Buy
Price Target: $1,280 → $1,330
Current: $1,115.70
Upside: +19.21%
Aug 5, 2026
Reiterated: Hold
Price Target: $28
Current: $27.72
Upside: +1.01%
Aug 4, 2026
Rated: Buy
Price Target: $550
Current: $515.44
Upside: +6.70%
Jul 31, 2026
Rated: Hold
Price Target: $60 → $65
Current: $63.64
Upside: +2.14%
Jul 31, 2026
Rated: Buy
Price Target: $200
Current: $156.22
Upside: +28.02%
Jul 30, 2026
Reiterated: Buy
Price Target: $250
Current: $217.15
Upside: +15.13%
May 5, 2026
Reiterated: Hold
Price Target: $5
Current: $4.08
Upside: +22.55%
Apr 1, 2026
Reiterated: Buy
Price Target: $13
Current: $4.59
Upside: +183.22%
Aug 12, 2025
Reiterated: Buy
Price Target: $47
Current: $58.65
Upside: n/a
Jul 2, 2021
Reiterated: Buy
Price Target: $95
Current: $82.85
Upside: n/a
Jun 29, 2021
Reiterated: Buy
Price Target: $30 → $14
Current: $37.44
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $3
Current: $0.0001
Upside: n/a
Apr 5, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $1.17
Upside: n/a
Mar 24, 2021
Reiterated: Buy
Price Target: $20 → $33
Current: $37.59
Upside: n/a
Feb 25, 2021
Reiterated: Buy
Price Target: $25 → $27
Current: $1.33
Upside: n/a
Jan 20, 2021
Reiterated: Buy
Price Target: $36 → $75
Current: $6.20
Upside: n/a
Jan 5, 2021
Reiterated: Buy
Price Target: $10 → $5
Current: $0.0001
Upside: n/a
Dec 23, 2020
Reiterated: Buy
Price Target: $75 → $65
Current: $33.60
Upside: n/a
Sep 15, 2020
Reiterated: Hold
Price Target: $11 → $8.5
Current: $3.29
Upside: n/a
Apr 27, 2020
Reiterated: Buy
Price Target: $8 → $5
Current: $0.02265
Upside: n/a
Jun 11, 2019
Initiated Coverage: Buy
Price Target: $21
Current: $14.81
Upside: n/a